# Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease

> **NCT03738475** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 34 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **DRUG:** TIMP-GLIA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03738475
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-11
- **Primary completion:** 2019-06-24
- **Final completion:** 2019-07-22
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2020-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03738475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03738475, "Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03738475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*